Otonomy Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Back to Jobs

OTO -313 Phase 2 trial in tinnitus ongoing with results expected in mid-2022 OTO -413 Phase 1/2 trial expansion in hearing loss ongoing with results expected in mid-2022 OTO -825 preclinical proof-of-concept results presented at ASGCT meeting; Pre-IND meeting complete and IND-enabling activities

Apply Now